Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Methoxy-polyethylene glycol-epoetin Beta (b03xa03 (open-house model)

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Sevelamer hydrochloride (v03ae02) within the framework of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient buserelin (l02ae01) within the framework of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient fusidic acid (d06ax01) as part of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient dabigatran (b01ae07) as part of a so-called open-house model.
251-260 of 294 active Tenders